Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results matching your filters

Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CICRecruiting
NCT05491525Phase 2, Phase 3Updated Jun 15, 2026
Sponsor: Urovant Sciences GmbH
Neurogenic Detrusor Overactivity
United States, Belgium, Canada, Croatia, Denmark +11 more
Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib for the Treatment of Polyarticular-course Juvenile Idiopathic Arthritis in Children and AdolescentsRecruiting
NCT07554495Phase 3Updated Jun 12, 2026
Sponsor: Alfasigma S.p.A.
Polyarticular Course Juvenile Idiopathic Arthritis
Belgium, Czechia, France, Germany, Hungary +4 more
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib TherapyRecruiting
NCT07218926Phase 3Updated Jun 12, 2026
Sponsor: GlaxoSmithKline
Gastrointestinal Neoplasms
United States, Australia, Belgium, Brazil, Canada +14 more
Evaluation of Efficacy and Safety of Rituximab and Mycophenolate Mofetil Combination in Patients With Interstitial Lung Disease Related to Systemic SclerosisRecruiting
NCT06549231Phase 3Updated Jun 12, 2026
Sponsor: University Hospital, Tours
Interstitial Lung Disease With Systemic Sclerosis
France
LA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atrial Strain.Recruiting
NCT07202897Phase 3Updated Jun 12, 2026
Sponsor: Rennes University Hospital
Hypertrophic Cardiomyopathy (HCM)
France
Topical Cryotherapy and Keloid/Hypertrophic ScarsRecruiting
NCT07336368Phase 3Updated Jun 12, 2026
Sponsor: Sonal Choudhary
Keloid Scars · Hypertrophic Scars
United States
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast CancerRecruiting
NCT05950945Phase 3Updated Jun 12, 2026
Sponsor: Daiichi Sankyo
Breast Cancer
United States, Australia, Belgium, Brazil, China +5 more
Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing ChemotherapyRecruiting
NCT06763328Phase 3Updated Jun 12, 2026
Sponsor: City of Hope Medical Center
Anatomic Stage I Breast Cancer AJCC v8 · Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8 · Invasive Breast Carcinoma
United States
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic MigraineRecruiting
NCT05164172Phase 3Updated Jun 12, 2026
Sponsor: H. Lundbeck A/S
Migraine
United States, Argentina, Canada, Italy, Mexico +6 more
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)Recruiting
NCT07456696Phase 3Updated Jun 12, 2026
Sponsor: Transcend Therapeutics
Post Traumatic Stress Disorder
United States
Chronic Hypertension and Acetyl Salicylic Acid in PregnancyRecruiting
NCT04356326Phase 3Updated Jun 12, 2026
Sponsor: Centre Hospitalier Intercommunal Creteil
Chronic Hypertension Complicating Pregnancy · Pre-Eclampsia · Intrauterine Growth Restriction · Aspirin
France
The Effect of Medical Management Following Excisional Surgery for Endometriosis: A Randomized Controlled TrialRecruiting
NCT06439524Phase 3Updated Jun 12, 2026
Sponsor: Main Line Health
Endometriosis
United States
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for TransplantRecruiting
NCT07095452Phase 2, Phase 3Updated Jun 11, 2026
Sponsor: AbbVie
Multiple Myeloma
United States, France, Japan, Spain
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque PsoriasisRecruiting
NCT07362017Phase 3Updated Jun 11, 2026
Sponsor: Vanda Pharmaceuticals
Moderate-to-severe Chronic Plaque Psoriasis
United States
A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)Recruiting
NCT06367972Phase 2, Phase 3Updated Jun 11, 2026
Sponsor: M.D. Anderson Cancer Center
OligoProgressive Metastatic Disease
United States
PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After FixationRecruiting
NCT05699174Phase 3Updated Jun 11, 2026
Sponsor: Major Extremity Trauma Research Consortium
Infections · Infected Wound · Nonunion of Fracture · Injury Leg
United States
Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients With Mild to Moderately Active Ulcerative ColitisRecruiting
NCT06488625Phase 2, Phase 3Updated Jun 11, 2026
Sponsor: University Hospital Schleswig-Holstein
Ulcerative Colitis, Unspecified
Germany
An Extension Study for Patients Previously Enrolled in Studies With PelabresibRecruiting
NCT06401356Phase 3Updated Jun 11, 2026
Sponsor: Novartis Pharmaceuticals
Hematologic Malignancy · Solid Tumor · Advanced Malignancies
United States, Belgium, Italy, Netherlands, United Kingdom
Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant RecipientsRecruiting
NCT06407232Phase 3Updated Jun 11, 2026
Sponsor: University of Wisconsin, Madison
Cytomegalovirus Infections · Kidney Transplant Infection · Pancreas Transplant
United States
Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney CancerRecruiting
NCT07383441Phase 3Updated Jun 11, 2026
Sponsor: SWOG Cancer Research Network
Advanced Clear Cell Renal Cell Carcinoma · Metastatic Clear Cell Renal Cell Carcinoma · Stage III Renal Cell Cancer AJCC v8 · Stage IV Renal Cell Cancer AJCC v8
United States
Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1Recruiting
NCT05593458Phase 3Updated Jun 11, 2026
Sponsor: Zhejiang University
Locally Advanced Gastric Carcinoma
China
STI Testing to Enhance PrEP Use in PregnancyRecruiting
NCT06919614Phase 3Updated Jun 11, 2026
Sponsor: Botswana Harvard AIDS Institute Partnership
PrEP Adherence · Sexually Transmitted Infections (STIs) · Pregnancy
Botswana
Justification And Evaluation of Baricitinib Plus Corticosteroids Versus corticosteroiDs Alone in pOlymyalgia RhEumaticaRecruiting
NCT07279688Phase 3Updated Jun 10, 2026
Sponsor: University Hospital, Brest
Polymyalgia Rheumatica (PMR)
France
GB06 Phase III Trial for Pediatric Growth Hormone DeficiencyRecruiting
NCT07553351Phase 3Updated Jun 10, 2026
Sponsor: Kexing Biopharm Co., Ltd.
Growth Hormone Deficiency (GHD) · Growth Hormone Deficiency in Children · Growth Hormone Deficiency, Pediatric
China
In Vivo Involvement of the Cholinergic and Dopaminergic Systems in the Pathophysiology of Apathy.Recruiting
NCT03998852Phase 3Updated Jun 10, 2026
Sponsor: University Hospital, Bordeaux
Apathy
France

Previous page Next page